Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Kayvon Modjarrad(Walter Reed Army Institute of Research), Nelson L. Michael(Walter Reed Army Institute of Research), Andrew J. Hale(University of Vermont Medical Center), Christine A. Bricault(Beth Israel Deaconess Medical Center), Chen Sabrina Tan(Beth Israel Deaconess Medical Center), Michael Boyd, Stephen R. Walsh(Beth Israel Deaconess Medical Center), Jason Thompson(Emmes (United States)), Sarah L. George(Saint Louis University), Rafael A. Larocca(Beth Israel Deaconess Medical Center), Daniel F. Hoft(Saint Louis University), Kathryn E. Stephenson(Beth Israel Deaconess Medical Center), Keith Meyer(Saint Louis University), Peter Abbink(Beth Israel Deaconess Medical Center), Anne Basil(Henry M. Jackson Foundation), Dan H. Barouch(Beth Israel Deaconess Medical Center), Stephen J. Thomas(Walter Reed Army Institute of Research), Trevor A. Crowell(Henry M. Jackson Foundation), James D. Brien(Saint Louis University), Rafael A. De La Barrera(Walter Reed Army Institute of Research), Kenneth H. Eckels(Walter Reed Army Institute of Research), Kristin T Mills(Walter Reed Army Institute of Research), Melissa J Walsh(Henry M. Jackson Foundation), Merlin L. Robb(University of Maryland, Baltimore), Richard G. Jarman(Walter Reed Army Institute of Research), Michael S. Seaman(Beth Israel Deaconess Medical Center), Janice Tennant(Saint Louis University), Azra Blazevic(Saint Louis University), Erica L Sondergaard(Walter Reed Army Institute of Research), Michael Koren(Jacksonville University), Jessica L. Ansel(Beth Israel Deaconess Medical Center), Peter Dawson(Emmes (United States)), Jill Barrett(Emmes (United States)), Karla J Mosby(Saint Louis University), Alison E Kosel(Emmes (United States)), Leyi Lin(Walter Reed Army Institute of Research), Veronica Tutse-Tonwe(Henry M. Jackson Foundation)
Cited by 196
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
|Science|2020|1.1k